Ying‐zi Xu

592 citations
21 papers · 347 indexed · h-index 11
Topics
Alzheimer's disease research and treatments (4 papers)Computational Drug Discovery Methods (4 papers)Chemical Synthesis and Analysis (3 papers)
Partner nations
United StatesChinaCanada

In The Last Decade

Ying‐zi Xu

19 papers receiving 334 citations

Peers

Ying‐zi Xu
Comparison fields: 5 of 64
  • Organic Chemistry 150
  • Molecular Biology 133
  • Pharmacology 66
  • Physiology 63
  • Computational Theory and Mathematics 59
Replace A. Mayweg with:
A. Mayweg Switzerland
Alan M. Birch United Kingdom
Hitoshi Kurata Japan
Yanshen Guo China
Hongchan An South Korea
Wenhai Huang China
Ravi Naik South Korea
Iván Kanizsai Hungary
Brianne S. Raccor United States
Kshitij Thakkar United States
Ying‐zi Xu relative to A. Mayweg Switzerland A. Mayweg's profile →
Citations per field
00.5×
A. Mayweg · 1×
Citations per year

Countries citing papers authored by Ying‐zi Xu

Since Specialization
Citations

This map shows the geographic impact of Ying‐zi Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying‐zi Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying‐zi Xu more than expected).

Fields of papers citing papers by Ying‐zi Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ying‐zi Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying‐zi Xu. The network helps show where Ying‐zi Xu may publish in the future.

Co-authorship network of co-authors of Ying‐zi Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Ying‐zi Xu. A scholar is included among the top collaborators of Ying‐zi Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ying‐zi Xu. Ying‐zi Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 2
4 5
5 70
6 1
7 11
8 21
9 5
10 6
11 10
12 60
13 4
14 2
15 14
16 32
17 55
18 10
19 17
20 12

About Ying‐zi Xu

Ying‐zi Xu is a scholar working on Immunology and Allergy, Computational Theory and Mathematics and Pharmacology, having authored 21 papers that have together received 347 indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (4 papers), Computational Drug Discovery Methods (4 papers) and Chemical Synthesis and Analysis (3 papers). The work is most often cited by research in Organic Chemistry (150 citations), Biotechnology (41 citations) and Pharmacology (66 citations). Ying‐zi Xu has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Kenichi Yakushijin, Gary D. Probst, David Horne, Christopher T. Jones, Randall L. Halcomb, Martijn Fenaux, F. Anthony Romero, Jaesung Choi, Sean Turner and Manuel Calaza. Their work appears in journals such as Biochemical and Biophysical Research Communications, Journal of Medicinal Chemistry and Journal of Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026